Juan
Cabezas Herrera
Publications by the researcher in collaboration with Juan Cabezas Herrera (24)
2023
-
Targeting protein methylation in pancreatic cancer cells results in KRAS signaling imbalance and inhibition of autophagy
Cell Death and Disease, Vol. 14, Núm. 11
2021
-
Acriflavine, a potent inhibitor of HIF-1α, disturbs glucose metabolism and suppresses ATF4-protective pathways in melanoma under non-hypoxic conditions
Cancers, Vol. 13, Núm. 1, pp. 1-17
-
MITF induces escape from innate immunity in melanoma
Journal of Experimental and Clinical Cancer Research, Vol. 40, Núm. 1
2020
-
PRMT1-dependent methylation of BRCA1 contributes to the epigenetic defense of breast cancer cells against ionizing radiation
Scientific Reports, Vol. 10, Núm. 1
2017
-
Lipid rafts of mouse liver contain nonextended and extended acetylcholinesterase variants along with M3 muscarinic receptors
FASEB Journal, Vol. 31, Núm. 2, pp. 544-555
2016
-
Cholinergic system and cell proliferation
Chemico-Biological Interactions, Vol. 259, pp. 257-265
-
Targeting the epigenetics of the DNA damage response in breast cancer
Cell Death and Disease, Vol. 7
-
Tumor suppressor SET9 guides the epigenetic plasticity of breast cancer cells and serves as an early-stage biomarker for predicting metastasis
Oncogene, Vol. 35, Núm. 47, pp. 6143-6152
2015
-
Dysregulated cholinergic network as a novel biomarker of poor prognostic in patients with head and neck squamous cell carcinoma
BMC Cancer, Vol. 15, Núm. 1
-
Targeting the epigenetic machinery of cancer cells
Oncogene, Vol. 34, Núm. 2, pp. 135-143
2014
-
Most acetylcholinesterase activity of non-nervous tissues and cells arises from the AChE-H transcript
Journal of Molecular Neuroscience, Vol. 53, Núm. 3, pp. 429-435
2013
-
Directed Phenotype Switching as an Effective Antimelanoma Strategy
Cancer Cell, Vol. 24, Núm. 1, pp. 105-119
-
Suppression of antifolate resistance by targeting the myosin Va trafficking pathway in melanoma
Neoplasia (United States), Vol. 15, Núm. 7, pp. 826-839
-
The AChE membrane-binding tail PRiMA is down-regulated in muscle and nerve of mice with muscular dystrophy by merosin deficiency
Chemico-Biological Interactions
2012
-
Changes in the expression and structure of cholinesterases in excitable and non-excitable tissues of the merosin-deficient Lama2dy mouse, a model of congenital muscular dystrophy
Cholinesterase: Production, Uses and Health Effects (Nova Science Publishers, Inc.), pp. 1-32
-
Melanoma coordinates general and cell-specific mechanisms to promote methotrexate resistance
Experimental Cell Research, Vol. 318, Núm. 10, pp. 1146-1159
-
Reactivation of the Tumour Suppressor RASSF1A in Breast Cancer by Simultaneous Targeting of DNA and E2F1 Methylation
PLoS ONE, Vol. 7, Núm. 12
2011
-
Comparison of a Pair of Synthetic Tea-Catechin-Derived Epimers: Synthesis, Antifolate Activity, and Tyrosinase-Mediated Activation in Melanoma
ChemMedChem, Vol. 6, Núm. 3, pp. 440-449
2010
-
Expression of cholinesterases in human kidney and its variation in renal cell carcinoma types
FEBS Journal, Vol. 277, Núm. 21, pp. 4519-4529
-
Mechanism of dihydrofolate reductase downregulation in melanoma by 3-O-(3,4,5-trimethoxybenzoyl)-(-)-epicatechin
Journal of Cellular Biochemistry, Vol. 110, Núm. 6, pp. 1399-1409